Am J Perinatol 2004; 21(1): 1-8
DOI: 10.1055/s-2004-820502
Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA

The Effect of Antenatal Corticosteroids on Fetal Growth, Survival, and Neurodevelopmental Outcome in Triplet Pregnancies

Angela D'Amore1 , Jag Ahluwalia1 , Irfan Cheema1 , Andrew Prentice2 , Stephen Kaptoge3 , Wilf Kelsall1
  • 1Neonatal Intensive Care Unit, Addenbrookes Hospital, Cambridge, United Kingdom
  • 2Department of Obstetrics and Reproductive Medicine, University of Cambridge, Addenbrookes Hospital, Cambridge, United Kingdom
  • 3Centre for Applied Medical Statistics, Institute of Public Health, Department of Community Medicine, University of Cambridge, United Kingdom
Further Information

Publication History

Publication Date:
11 March 2004 (online)

Preview

Triplet pregnancies have increased as a result of infertility therapy. The objectives of this study are to review the outcome of triplet pregnancies and to determine the effect of different antenatal corticosteroid treatments on fetal growth, survival, and neurodevelopmental outcome. A retrospective case note review of infant and maternal records from a single tertiary neonatal unit was performed from January 1, 1986, through December 31, 1999; 173 live births from 60 triplet pregnancies were divided into groups according to maternal antenatal corticosteroid exposure. Logistic regression model showed only gestation had a significant effect on survival. There was no adverse effect of steroid exposure on weight or head circumference at birth. Ninety percent of live births survived to discharge. Of 143 survivors, only five infants had documented neurodevelopmental problems. Survival rate in triplet pregnancy is high. In this analysis of cohort data repetitive antenatal steroids were not associated with adverse outcome.

REFERENCES

Wilf KelsallB.Sc. 

Neonatal Intensive Care Unit

Box 226, Addenbrookes Hospital, Hills Road

Cambridge CB2 2QQ, United Kingdom